| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| JAK2 |
4-[[4-Amino-6-[5-(hydroxymethyl)furan-2-yl]-1,3,5-triazin-2-yl]amino]benzonitrile |
NA |
NA |
122300 |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1R,2R,5S)-5-hydroxy-2-[4-oxo-3-[4-(trifluoromethyl)anilino]-3,3a,5,6,7,7a-hexahydro-2H-pyrazolo[4,3-c]pyridin-1-yl]cyclohexane-1-carbonitrile |
NA |
117000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1S,2S,5R)-2-[3-(4-chlorophenyl)imino-4-oxo-2,3a-dihydropyrazolo[4,3-c]pyridin-1-yl]-5-[[(1S)-1-cyclopropylethyl]amino]cyclohexane-1-carbonitrile |
NA |
122000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1R,2R,5R)-2-[3-(4-chlorophenyl)imino-4-oxo-2,3a-dihydropyrazolo[4,3-c]pyridin-1-yl]-5-[[(1S)-1-cyclopropylethyl]amino]cyclohexane-1-carbonitrile |
NA |
525000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1S,2S,5R)-2-[3-(4-chloro-3-fluoroanilino)-4-oxo-3,3a,5,6,7,7a-hexahydro-2H-pyrazolo[4,3-c]pyridin-1-yl]-5-[[(1S)-1-cyclopropylethyl]amino]cyclohexane-1-carbonitrile |
NA |
113000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1R,2R,5S)-5-(azetidin-1-yl)-2-[4-oxo-3-[4-(trifluoromethyl)anilino]-3,3a,5,6,7,7a-hexahydro-2H-pyrazolo[4,3-c]pyridin-1-yl]cyclohexane-1-carbonitrile |
NA |
660000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1R,2R,5R)-5-(azetidin-1-yl)-2-[4-oxo-3-[4-(trifluoromethyl)anilino]-3,3a,5,6,7,7a-hexahydro-2H-pyrazolo[4,3-c]pyridin-1-yl]cyclohexane-1-carbonitrile |
NA |
940000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1S,2S,5R)-5-[[(1S)-1-cyclopropylethyl]amino]-2-[4-oxo-3-[4-(trifluoromethyl)anilino]-3,3a,5,6,7,7a-hexahydro-2H-pyrazolo[4,3-c]pyridin-1-yl]cyclohexane-1-carbonitrile |
NA |
106000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1R,2R,5R)-5-[[(1S)-1-cyclopropylethyl]amino]-2-[4-oxo-3-[4-(trifluoromethyl)anilino]-3,3a,5,6,7,7a-hexahydro-2H-pyrazolo[4,3-c]pyridin-1-yl]cyclohexane-1-carbonitrile |
NA |
580000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
(1S,2S,5R)-5-[[(1S)-1-cyclopropylethyl]amino]-2-[4-oxo-3-[4-(trifluoromethoxy)anilino]-3,3a,5,6,7,7a-hexahydro-2H-pyrazolo[4,3-c]pyridin-1-yl]cyclohexane-1-carbonitrile |
NA |
233000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
US11279703, Table 6.217 |
NA |
1000000 |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
N-(pyridin-4-yl)-3-[1-(4-chlorobenzyl)indol-3-yl]-propanamide |
NA |
133600 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| JAK2 |
6-[[5-(cyclopentylmethylamino)-1,3,4-thiadiazol-2-yl]sulfanylmethyl]-2-N-(4-fluorophenyl)-1,3,5-triazine-2,4-diamine |
NA |
NA |
149000 |
NA |
NA |
NA |
BindingDB |
| JAK2 |
6-bromo-1H-indazol-3-amine |
NA |
131000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| JAK2 |
Dasatinib |
1000000 |
NA |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
3-[1-(4-Chlorobenzyl)-1h-indol-3-yl]-n-(4-nitrophenyl)propanamide |
NA |
106700 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| JAK2 |
Src kinase inhibitor PP2 |
NA |
50000000 |
NA |
NA |
NA |
NA |
TTD |
| JAK2 |
(3R)-1-[[1-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methylpyrrol-3-yl]methyl]pyrrolidin-3-ol |
NA |
115300 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| JAK2 |
Sunitinib |
410000 |
NA |
NA |
NA |
NA |
NA |
BindingDB |
| JAK2 |
Jnj-7706621 |
220000 |
NA |
NA |
NA |
NA |
NA |
BindingDB |